Evolent Health Newsroom

Evolent Health Price Target Cut to $15.00/Share From $45.00 by JP Morgan

Dow JonesNov 22 10:30 ET

J.P. Morgan Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $15

Moomoo NewsNov 22 07:32 ET

Oppenheimer Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $28

Moomoo NewsNov 19 03:37 ET

Evolent Health Is Maintained at Outperform by Oppenheimer

Dow JonesNov 18 09:09 ET

Oppenheimer Maintains Outperform on Evolent Health, Lowers Price Target to $28

BenzingaNov 18 09:00 ET

Evolent Health Analyst Ratings

BenzingaNov 18 08:59 ET

Citi Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $21

Moomoo NewsNov 13 07:31 ET

RBC Capital Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $20

Moomoo NewsNov 13 01:31 ET

Evolent Health Price Target Maintained With a $20.00/Share by RBC Capital

Dow JonesNov 12 10:50 ET

A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $19 to $36

Moomoo NewsNov 12 08:04 ET

RBC Capital Sticks to Its Buy Rating for Evolent Health (EVH)

TipRanksNov 12 06:38 ET

Evolent Health Is Maintained at Overweight by Barclays

Dow JonesNov 11 09:17 ET

Evolent Health Analyst Ratings

BenzingaNov 11 09:08 ET

Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $24

Moomoo NewsNov 11 07:34 ET

Barclays Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $19

Moomoo NewsNov 11 03:34 ET

A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $27 to $63

Moomoo NewsNov 9 08:10 ET

Evolent Health Is Maintained at Outperform by Oppenheimer

Dow JonesNov 8 11:21 ET

RBC Capital Adjusts Evolent Health Price Target to $20 From $42, Maintains Outperform Rating

MT NewswiresNov 8 10:03 ET

Evolent Health Price Target Announced at $16.00/Share by Stephens & Co.

Dow JonesNov 8 07:26 ET

Evolent Health Analyst Ratings

BenzingaNov 8 07:17 ET